Pacira BioSciences, Inc.

PCRX US Health Care Pharmaceuticals
S&P 600
$25.36
+0.79%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Pacira BioSciences, Inc. belong to?
Pacira BioSciences, Inc. operates in the Health Care sector, specifically the Pharmaceuticals industry, and is listed on the US markets.
What is the current share price of PCRX?
As of the latest available quote, PCRX traded at $25.36. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of PCRX?
Pacira BioSciences, Inc. has a price-to-earnings (P/E) ratio of about 72.46. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of PCRX?
The market capitalisation of Pacira BioSciences, Inc. is approximately $1.11B.
Is Pacira BioSciences, Inc. profitable?
For its latest reported financial year, Pacira BioSciences, Inc. recorded a net profit margin of about 0.97%.
Does PCRX pay a dividend?
Pacira BioSciences, Inc. does not currently show a dividend yield in our data.
What is the return on equity (ROE) of PCRX?
Pacira BioSciences, Inc. has a return on equity (ROE) of about 1.05%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of PCRX?
Over the past 52 weeks, PCRX has traded between a low of $18.80 and a high of $27.66.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.